Bishnu P Dhakal1, Guilherme H Oliveira2. 1. Harrington Heart and Vascular Institute, Division of Heart Failure and Cardiac Transplant, Department of Medicine University Hospitals Cleveland Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Mailstop LKS 5038, Cleveland, OH, 44106, USA. 2. Harrington Heart and Vascular Institute, Division of Heart Failure and Cardiac Transplant, Department of Medicine University Hospitals Cleveland Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Mailstop LKS 5038, Cleveland, OH, 44106, USA. guilherme.oliveira@uhhospitals.org.
Abstract
PURPOSE OF THE REVIEW: Percutaneous ventricular restoration with a ventricular partitioning device (VPD) is a novel minimally invasive procedure designed to restore the left ventricular (LV) shape by isolating the infarcted and aneurysmal LV apex from remainder of the cavity in heart failure patients with severely reduced LV ejection fraction. In this review, we perform an in-depth analysis of the design and purpose of the VPD and review the available clinical data, with special attention to hemodynamics, outcomes, and complications. RECENT FINDINGS: PARACHUTE trials have shown >90% procedural success rate of VPD implant. Heart failure patients had improvement in hemodynamics (reduction in LV volumes and increase in LV ejection fraction) and functional status (6-min walking distance and quality of life scores) after the VPD implant. Optimal implant position is necessary to obtain a good clinical outcome. Percutaneous VPD implantation has thus far been a safe intervention capable of improving surrogate markers of heart failure but there is still a need to develop more durable devices with a long-lasting hemodynamics effect.
PURPOSE OF THE REVIEW: Percutaneous ventricular restoration with a ventricular partitioning device (VPD) is a novel minimally invasive procedure designed to restore the left ventricular (LV) shape by isolating the infarcted and aneurysmal LV apex from remainder of the cavity in heart failurepatients with severely reduced LV ejection fraction. In this review, we perform an in-depth analysis of the design and purpose of the VPD and review the available clinical data, with special attention to hemodynamics, outcomes, and complications. RECENT FINDINGS: PARACHUTE trials have shown >90% procedural success rate of VPD implant. Heart failurepatients had improvement in hemodynamics (reduction in LV volumes and increase in LV ejection fraction) and functional status (6-min walking distance and quality of life scores) after the VPD implant. Optimal implant position is necessary to obtain a good clinical outcome. Percutaneous VPD implantation has thus far been a safe intervention capable of improving surrogate markers of heart failure but there is still a need to develop more durable devices with a long-lasting hemodynamics effect.
Authors: Ilkay Bozdag-Turan; Benjamin Bermaoui; R Goekmen Turan; Stephan Kische; Liliya Paranskaya; Katja Kloker; Jasmin Ortak; Ibrahim Akin; Karlheinz Hauenstein; Christoph A Nienaber; Hueseyin Ince Journal: Cardiovasc Ther Date: 2014-02 Impact factor: 3.023
Authors: Guilherme H Oliveira; Sadeer G Al-Kindi; Hiram G Bezerra; Marco A Costa Journal: J Cardiovasc Transl Res Date: 2014-02-27 Impact factor: 4.132
Authors: Maria Rosa Costanzo; Russell J Ivanhoe; Andrew Kao; Inder S Anand; Alan Bank; John Boehmer; Teresa Demarco; Cheryl M Hergert; Richard G Holcomb; Simon Maybaum; Benjamin Sun; Thomas A Vassiliades; Barry K Rayburn; William T Abraham Journal: J Card Fail Date: 2012-06 Impact factor: 5.712
Authors: B A Groenning; J C Nilsson; L Sondergaard; T Fritz-Hansen; H B Larsson; P R Hildebrandt Journal: J Am Coll Cardiol Date: 2000-12 Impact factor: 24.094
Authors: P Lechat; S Escolano; J L Golmard; H Lardoux; S Witchitz; J A Henneman; B Maisch; M Hetzel; P Jaillon; J P Boissel; A Mallet Journal: Circulation Date: 1997-10-07 Impact factor: 29.690